Skip to main content
logo
AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
5.05
+0.15 (3.06%)
At close: Sep 18, 2026, 4:00 PM EDT
5.04
-0.01 (-0.20%)
After-hours: Sep 18, 2026, 7:30 PM EDT

AN2 Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Cash & Equivalents
44.3253.4919.941818.2219.9921.3533.526.7724.6915.6532.6240.8126.7127.2228.840.6282.5212.1-
Short-Term Investments
34.0731.838.0643.9244.747.0862.2759.9277.7789.5291.6591.254.4561.8168.8475.5872.7735.8446.46-
Cash & Short-Term Investments
78.3985.295861.9262.9267.0683.6293.43104.54114.21107.3123.8295.2688.5296.06104.38113.39118.3558.56-
Cash Growth (YoY)
24.59%27.18%-30.64%-33.72%-39.82%-41.28%-22.07%-24.55%9.74%29.03%11.70%18.62%-15.99%-25.21%64.05%--2807.96%--
Other Receivables
0.310.90.60.40.30.310.3-1.4---------
Receivables
0.310.90.60.40.30.310.3-1.4---------
Prepaid Expenses
1.31.21.041.54.212.22.343.262.62.11.812.592.941.772.512.843.481.41.55-
Other Current Assets
------------0.010.030.050.070.010.03--
Total Current Assets
79.9987.4959.9464.0267.5269.5686.2697.69107.44116.31110.51126.4198.2190.3298.62107.3116.88119.7860.11-
Long-Term Investments
1.47-2.013.228.311.485.02--3.927.1926.36--3.221.992.42-3.49-
Long-Term Deferred Charges
-------------0.05----1.72-
Other Long-Term Assets
0.22----0.30.8-1.041.041.041.040.720.720.720.720.720.72--
Total Assets
81.6887.4961.9567.2475.8381.3492.0997.69108.48121.26138.74153.8198.9391.08102.56110.01120.02120.565.32-

Liabilities

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Accounts Payable
1.972.623.022.232.113.073.321.711.892.432.684.883.133.552.121.441.612.611.06-
Accrued Expenses
2.842.384.474.454.154.576.137.037.687.9110.78.997.824.935.012.912.511.292-
Current Portion of Leases
------------0.010.030.050.070.010.03--
Other Current Liabilities
0.780.571.230.180.720.370.791.280.560.320.670.980.20.050.010.010.021.160.33-
Total Current Liabilities
5.595.568.726.866.988.0110.2410.0210.1310.6614.0414.8411.168.577.194.434.155.093.4-
Other Long-Term Liabilities
0.170.170.17---------000000.010.01-
Total Liabilities
5.765.738.896.866.988.0110.2410.0210.1310.6614.0414.8411.168.577.194.444.155.093.41-

Shareholders' Equity

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Additional Paid-In Capital
335.11332.74293.95292.55291.7289.71287.59285.81283.89281.62278.88276.65208.73187.74185.47184182.77171.99--
Retained Earnings
-259.16-250.98-240.95-232.24-222.89-216.43-205.78-198.25-185.51-171.07-154.46-137.56-120.85-105.05-89.72-77.88-66.54-56.42-47.38-
Comprehensive Income & Other
-0.02-0.010.060.060.030.050.030.11-0.030.050.28-0.12-0.12-0.18-0.37-0.54-0.36-0.16-0.03-
Total Common Equity
75.9281.7653.0660.3868.8473.3381.8587.6798.35110.6124.7138.9787.7682.5295.37105.57115.86115.41-47.41-
Shareholders' Equity
75.9281.7653.0660.3868.8473.3381.8587.6798.35110.6124.7138.9787.7682.5295.37105.57115.86115.4161.91-
Total Liabilities & Equity
81.6887.4961.9567.2475.8381.3492.0997.69108.48121.26138.74153.8198.9391.08102.56110.01120.02120.565.32-

Additional Metrics

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Total Debt
------------0.010.030.050.070.010.03--
Net Cash (Debt)
78.3985.295861.9262.9267.0683.6293.43104.54114.21107.3123.8295.2588.4896.01104.31113.38118.3258.56-
Net Cash Growth (YoY)
24.59%27.18%-30.64%-33.72%-39.82%-41.28%-22.07%-24.55%9.76%29.08%11.76%18.70%-15.99%-25.22%63.96%--2807.17%--
Net Cash Per Share
1.752.501.912.052.092.232.803.133.513.843.614.834.884.564.965.395.8937.2022.06-
Filing Date Shares Outstanding
37.7436.0235.9427.427.3330.1830.129.8829.8429.8329.7729.7421.9319.4319.419.419.419.42.732.64
Total Common Shares Outstanding
36.3135.9927.4127.3727.3830.1429.9229.8729.8329.8229.7429.7421.9319.4319.419.419.418.712.732.64
Working Capital
74.4181.9351.2257.1660.5461.5576.0287.6797.31105.6596.46111.5787.0581.7591.44102.86112.73114.756.71-
Book Value Per Share
2.092.271.942.212.512.432.742.943.303.714.194.674.004.254.925.445.976.17-17.36-
Tangible Book Value
75.9281.7653.0660.3868.8473.3381.8587.6798.35110.6124.7138.9787.7682.5295.37105.57115.86115.41-47.41-
Tangible Book Value Per Share
2.092.271.942.212.512.432.742.943.303.714.194.674.004.254.925.445.976.17-17.36-
SEC Filings: 10-K · 10-Q